The following primary antibodies were used: anti-EGFP (chicken; Life Technologies, A10262; 1:500), rabbit anti-Rx2 (Reinhardt et al., 2015 (link); 1:500), anti-tagRFP (rabbit; Evrogen, AB233; 1:500), anti-Pax6 (rabbit; Hiss Diagnostics, PRB-278P; 1:200), PKCα (rabbit; Santa Cruz, sc-208; 1:200), anti-GS (mouse; Chemicon, MAB302; 1:500), anti-Sox2 (rabbit; Genetex, GTX101506; 1:500), anti-HuC/D (mouse; Thermo Fisher, A21271; 1:500), anti-recoverin (rabbit; Millipore, AB5585; 1:500), anti-Zpr-1 (mouse; Zebrafish International Resource Center; 1:500), anti-DsRed (rabbit; Clontech, 632496; 1:500), anti-BrdU (rat; AbD Serotec, BU1/75; 1:200). The following secondary antibodies were used: anti-mouse Cy5 (Jackson ImmunoResearch, 715-175-151), anti-chicken 488 (Jackson ImmunoResearch, 703-485-155), anti-rat DyLight549 (Jackson ImmunoResearch, 112-505-143), anti-rabbit DyLight549 (Jackson ImmunoResearch), anti-mouse Alexa546 (Life Technologies, A-11030) and anti-rat Alexa633 (Life Technologies, A21094). DAPI (Sigma-Aldrich, D9564) nuclear counterstaining was performed as described by Inoue and Wittbrodt (2011) (link).
Free full text: Click here